Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Kiora Pharmaceuticals KPRX stock hiding in plain sight Risk Aversion 20260507 AmPub Edu APEI Annual Recap American Public Education notches 772 EPS beat topping estimates Haemonetics Corporation HAE Stock Holding Support Edges Higher 20260418 Palantir Technologies Finds New Growth Engine Beyond Government Contracts Mortgage Rates Retreat to 636 Despite Persistent Inflation Pressures Casella CWST Crushes Q1 2026 Estimates EPS 020 Tops Views Americans Job Anxiety Reaches MultiYear High Federal Reserve Survey Shows Dell Technologies LongTerm Outlook Key Growth Drivers and Risks Through 2030 AI Industry Emerges as Key Beneficiary in MuskAltman Legal Battle BiomX Inc Q4 2025 Earnings Large Earnings Miss Stirs Uncertainty No Revenue Reported ColgatePalmolive CL Q1 2026 Earnings Slight EPS Miss Offset by Positive Market Reaction NBTB Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher LivaNova Q1 2026 Earnings EPS Beats Estimates by 71 as Company Highlights Operational Efficiencies LGL Q1 2026 Earnings Sharp EPS Miss Amidst Minimal Revenue Disclosure BTC Digital Ltd BTCT Edges Higher on Modest Volume Technical Levels in Focus Prediction Market Investments Continue Despite Regulatory Uncertainty Corporate Earnings Calls Reveal Ongoing Commitment CMS Q1 2026 Earnings Beats EPS Estimates on Solid Utility Operations Egypts Gas Discovery Boom Raises Hopes for Upstream Revival but Import Challenges Persist Malibu Boats Inc Q1 2026 Earnings EPS Surges 80 Above Estimates Amidst Modest Stock Decline SIDU Q1 2026 Earnings Losses Narrow as Sidus Space Advances Satellite Production and Defense Contracts Fox Corporation FOXA Q1 2026 Earnings Strong EPS Beat Overshadowed by Broader Concerns PagSeguro Q1 2026 Earnings EPS Falls Short Stock Holds Steady IOVA Q1 2026 Earnings EPS Misses Estimates Amid Continued RD Progress NESR Q1 2026 Earnings EPS Beats Estimates by Nearly 20 Despite Limited Revenue Disclosure PLTK Q1 2026 Earnings EPS Misses Estimates by 518 as Stock Climbs 5 Galmed Pharmaceuticals Q4 2025 Earnings WiderthanExpected Loss Amid Pipeline Progress Amneal Pharmaceuticals Inc AMRX Q1 2026 Earnings Strong EPS Beat Driven by Operational Execution